| Pharmaceutical Salts
| [0048]
|
| Pharmaceutical Dosage Forms
| [0055]
|
| The Art, Science and Technology of Pharmaceutical Compounding
| [0055]
|
| Dosage Calculations
| [0055]
|
| Remington: The Science and Practice of Pharmacy
| [0055]
|
| J. Biomater Sci. Polym. Ed.
| [0071]
|
| Pharm. Res.
| [0071]
|
| J. Pharm. Pharmacol.
| [0071]
|
| J. Microencapsul.
| [0071]
|
| Curr. Opin. Biotechnol.
| [0071]
|
| Am. J. Hosp. Pharm.
| [0071]
|
| THE PHARMACOLOGICAL BASIS OF THERAPEUTICS
| [0229]
|
| Pharmaceutical Sciences
| [0230]
|
| Remington's Pharmaceutical Sciences
| [0242]
|
| Nat. Med.
| [0268]
|
| JNM
| [0268]
|
| Structure and function of cellular deoxyribonucleoside kinases
| [0342]
|
| Structure of human dCK suggests strategies to improve anticancer and antiviral therapy
| [0342]
|
| Requirement for deoxycytidine kinase in T and B lymphocyte development
| [0342]
|
| Nucleoside salvage pathway kinases regulate hematopoiesis by linking nucleotide metabolism with replication stress
| [0342]
|
| A deficiency in nucleoside salvage impairs murine lymphocyte development, homeostasis, and survival
| [0342]
|
| Deoxycytidine kinase regulates the G2/M checkpoint through interaction with cyclin-dependent kinase 1 in response to DNA damage
| [0342]
|
| Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradication
| [0342]
|
| Development of new deoxycytidine kinase inhibitors and noninvasive in vivo evaluation using positron emission tomography
| [0342]
|
| Structural characterization of new deoxycytidine kinase inhibitors rationalizes the affinity-determining moieties of the molecules
| [0342]
|
| Structural basis for the preference of UTP over ATP in human deoxycytidine kinase: illuminating the role of main-chain reorganization
| [0342]
|
| Structural basis for substrate promiscuity of dCK
| [0342]
|
| Role of biotransformation studies in minimizing metabolism-related liabilities in drug discovery
| [0342]
|
| Rearrangement of Acetylenic Keto Alcohols under Meyer-Schuster Reaction Conditions
| [0342]
|
| Solution-phase parallel synthesis with oligoethylene glycol sorting tags. Preparation of all four stereoisomers of the hydroxybutenolide fragment of murisolin and related acetogenins
| [0342]
|
| Highly enantioselective borane reduction of ketones catalyzed by chiral oxazaborolidines. Mechanism and synthetic implications
| [0342]
|
| Comparison of Simple Potential Functions for Simulating Liquid Water
| [0342]
|
| Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids
| [0342]
|
| Molecular modeling of organic and biomolecular systems using BOSS and MCPRO
| [0342]
|
| Free energies of hydration from a generalized Born model and an ALL-atom force field
| [0342]
|
| PDDG/PM3 and PDDG/MNDO: improved semiempirical methods
| [0342]
|
| Semianalytical Treatment of Solvation for Molecular Mechanics and Dynamics
| [0342]
|
| Nonenantioselectivity property of human deoxycytidine kinase explained by structures of the enzyme in complex with L- and D-nucleosides
| [0342]
|
| Guanylate kinases from human erythrocytes, hog brain, and rat liver
| [0342]
|
| MULTI-FORTE, a microcomputer program for modelling and simulation of pharmacokinetic data
| [0342]
|
| a simulation and modeling program for pharmacokinetic and pharmacodynamic data analysis
| [0342]
|
| Acta Crystallogr D Biol Crystallogr
| [0342]
|
| Teplyakov, A. Molecular replacement with MOLREP
| [0342]
|
| REFMAC5 for the refinement of macromolecular crystal structures
| [0342]
|
| Features and development of Coot
| [0342]
|
| a tool for high-throughput crystallography of protein-ligand complexes
| [0342]
|
| Molecular modeling of organic and biomolecular systems using BOSS and MCPRO
| [0342]
|
| Improved semiempirical heats of formation through the use of bond and group equivalents
| [0342]
|
| Nucleoside salvage pathway kinases regulate hematopoiesis by linking nucleotide metabolism with replication stress
| [0390]
|
| Thresholds of replication stress signaling in cancer development and treatment
| [0390]
|
| Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia
| [0390]
|
| Clinical phase I-II and pharmacokinetic study of high-dose thymidine given by continuous intravenous infusion
| [0390]
|
| Simultaneous analysis of eight nucleoside triphosphates in cell lines by liquid chromatography coupled with tandem mass spectrometry
| [0390]
|
| Activation of deoxycytidine kinase by gamma-irradiation and inactivation by hyperosmotic shock in human lymphocytes
| [0390]
|
| Kinetic properties and inhibition of human T lymphoblast deoxycytidine kinase
| [0390]
|
| Translating cancer research into targeted therapeutics
| [0390]
|
| Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers
| [0390]
|
| Hallmarks of cancer: the next generation
| [0390]
|
| DNA synthesis from unbalanced nucleotide pools causes limited DNA damage that triggers ATR-CHK1-dependent p53 activation
| [0390]
|
| Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation
| [0390]
|
| Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug
| [0390]
|
| Liquid chromatography-high resolution mass spectrometry analysis of fatty acid metabolism
| [0390]
|
| High-dose thymidine infusions in patients with leukemia and lymphoma
| [0390]
|
| Effect of high-dose thymidine infusions in patients with mycosis fungoides
| [0390]
|
| Principles of cancer therapy: oncogene and non-oncogene addiction
| [0390]
|
| Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells
| [0390]
|
| ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage
| [0390]
|
| Development of new deoxycytidine kinase inhibitors and noninvasive in vivo evaluation using positron emission tomography
| [0390]
|
| Structural characterization of new deoxycytidine kinase inhibitors rationalizes the affinity-determining moieties of the molecules
| [0390]
|
| Role of thymidine in biochemical modulation: a review
| [0390]
|
| Increased deoxycytidine kinase activity by etoposide in L1210 murine leukemic cells
| [0390]
|
| Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2'-deoxycytidine analog
| [0390]
|
| Interactions between deoxyribonucleotide and DNA synthesis
| [0390]
[0432]
|
| Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR
| [0390]
|
| Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway
| [0390]
|
| Imaging proliferation in vivo with [F-18]FLT and positron emission tomography
| [0390]
|
| Novel PET probes specific for deoxycytidine kinase
| [0390]
|
| Cyclodextrins. Toxicologic pathology
| [0390]
|
| Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo
| [0390]
|
| Requirement for deoxycytidine kinase in T and B lymphocyte development
| [0390]
|
| Targeting cancer metabolism: a therapeutic window opens
| [0390]
|
| The Metabolism of Tumors in the Body
| [0390]
|
| Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia
| [0390]
|
| Functional compartmentation of dCTP pools. Preferential utilization of salvaged deoxycytidine for DNA repair in human lymphoblasts
| [0390]
|
| Deoxycytidine kinase regulates the G2/M checkpoint through interaction with cyclin-dependent kinase 1 in response to DNA damage
| [0390]
|
| Novel Potent Inhibitors of Deoxycytidine Kinase Identified and Compared by Multiple Assays
| [0390]
|
| Mammalian Deoxyribonucleoside Kinases
| [0432]
|
| Structural Basis for Substrate Promiscuity of dCK
| [0432]
|
| Reaction of Human UMP-CMP Kinase with Natural and Analog Substrates
| [0432]
|
| Novel Role of 3-Phosphoglycerate Kinase, a Glycolytic Enzyme, in the Activation of L-Nucleoside Analogs, a new class of Anticancer and Antiviral Agents
| [0432]
|
| Requirement for Deoxycytidine Kinase in T and B Lymphocyte Development
| [0432]
|
| Nucleoside Salvage Pathway Kinases Regulate Hematopoiesis by Linking Nucleotide Metabolism with Replication Stress
| [0432]
|
| Substrate Specificity and Phosphorylation of Antiviral and Anticancer Nucleoside Analogs by Human Deoxyribonucleoside Kinases and Ribonucleoside Kinases
| [0432]
|
| Deoxycytidine kinase regulates the G2/M checkpoint through interaction with cyclin-dependent kinase 1 in response to DNA damage
| [0432]
|
| 5-Fluorocytosine Derivatives as Inhibitors of Deoxycytidine Kinase
| [0432]
|
| Novel Potent Inhibitors of Deoxycytidine Kinase Identified and Compared by Multiple Assays
| [0432]
|
| Irreversible Enzyme Inhibitors: Active-Site-Directed Inhibitors of Deoxycytidine Kinase
| [0432]
|
| Lead Optimization and Structure-based Design of Potent and Bioavailable Deoxycytidine Kinase Inhibitors
| [0432]
|
| Technology Insight: Advances in Molecular Imaging and an Appraisal of PET/CT Scanning
| [0432]
|
| PET/CT Imaging: The Incremental Value of Assessing the Glucose Metabolic Phenotype and the Structure of Cancers in a Single Examination
| [0432]
|
| Molecular Imaging of Cancer with Positron Emission Tomography
| [0432]
|
| Oncological Application of Positron Emission Tomography with Fluorine-18
| [0432]
|
| Positron Emission Tomography in Oncology: A Review
| [0432]
|
| Positron Emission Tomography as an Imaging Biomarker
| [0432]
|
| Present Role and Future Prospects of Positron Emission Tomography in Clinical Oncology
| [0432]
|
| 18F-FDG Uptake in Lung, Breast, and Colon Cancers: Molecular Biology Correlates and Disease Characterization
| [0432]
|
| The Role of Molecular Imaging in Drug Discovery and Development
| [0432]
|
| Positron Emission Tomography: Applications in Drug Discovery and Drug Development
| [0432]
|
| Positron Emission Tomography for Use in Microdosing Studies
| [0432]
|
| Noninvasive Prediction of Tumor Responses to Gemcitabine using Positron Emission Tomography
| [0432]
|
| Molecular Imaging of Lymphoid Organs and Immune Activation by Positron Emission Tomography with a new [18F]-labeled 2'-deoxycytidine Analog
| [0432]
|
| Novel PET Probes Specific for Deoxycytidine Kinase
| [0432]
|
| Bioluminescent assays for high-throughput screening
| [0432]
|
| Fluorine in Pharmaceuticals: Looking Beyond Intuition
| [0432]
|
| Metabolsim of Fluorine-containing
| [0432]
|
| Reactions of Some Ortho and Para Halogenated Aromatic Nitriles with Ethylenediamine: Selective Synthesis of Imidazolines
| [0432]
|
| Synthesis of 2-Oxazolone-4-Carboxylates from 3-Nosyloxy- and 3-Bromo-2-ketoesters
| [0432]
|
| Synthesis of Benzyl Bromides with Hexabromoacetone: an Alternative Path to Drug Intermediates
| [0432]
|
| 15N5)-Labeled Adenine Derivatives: Synthesis and Studies of Tautomerism by 15N NMR Spectroscopy and Theoretical Calculations
| [0432]
|
| Cloning and Expression of Human Deoxycytidine Kinase cDNA
| [0432]
|
| Nucleotide Specificity of Human Deoxycytidine Kinase
| [0432]
|
| The Monte Carlo Method
| [0432]
|
| High-Temperature Equation of State by a Perturbation Method
| [0432]
|
| Perspective on Free-Energy Perturbation Calculations for Chemical Equilibria
| [0432]
|
| Molecular Modeling of Organic and Biomolecular Systems Using BOSS and MCPRO
| [0432]
|
| Role of biotransformation studies in minimizing metabolism-related liabilities in drug discovery
| [0432]
|
| Application of Positron Emission Tomography in Drug Development
| [0432]
|
| Comparison of Simple Potential Functions for Simulating Liquid Water
| [0432]
|
| Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids
| [0432]
|